Pharma Partnerships SCRI has active collaborations with Pfizer and Bristol Myers Squibb and partnerships like Blood Cancer Institute, signaling readiness for expanded co-development, joint study designs, and scalable patient recruitment services across its 200-site network.

Multi-site Scale With over 200 locations across more than 20 states and a network of 1,300 physicians, SCRI offers a broad platform for site onboarding, regulatory support, and centralized trial management to accelerate trials.

Tech & Security The tech stack includes Medidata, Salesforce, Imperva and other enterprise tools, presenting opportunities for advanced analytics, eSource and security-focused data integration, and streamlined financial and travel workflows.

Early-Phase Focus SCRI’s history of more than 850 first-in-human trials and contributions to FDA-approved therapies highlights a strong capability in early-phase oncology research and potential for expanded trial design, patient recruitment, and adaptive protocol support.

International Growth Under SCRI International, Inc and leadership expansions, partnerships with national centers, and cross-border collaborations point to opportunities to offer global trial execution, regulatory readiness, and cross-country patient access programs.